VYNE - VYNE Therapeutics GAAP EPS of -$2.01 revenue of $0.1M
2023-11-13 08:43:06 ET
More on VYNE Therapeutics
- Vyne Therapeutics jumps 52% on positive data from trials and $88M financing
- Seeking Alpha’s Quant Rating on VYNE Therapeutics
- Historical earnings data for VYNE Therapeutics
- Financial information for VYNE Therapeutics
For further details see:
VYNE Therapeutics GAAP EPS of -$2.01, revenue of $0.1M